| Detected | Trial | Change |
|---|---|---|
| 2026-05-28 | NCT07555938 Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in… |
Recruitment opened |
| 2026-05-28 | NCT07555938 Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in… |
Trial sites expanded: 0 -> 4 locations |
| 2026-05-28 | NCT07555938 Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in… |
date change Primary completion moved earlier: 2029-06-29 -> 2028-10-31 |
| 2026-05-28 | NCT07555938 Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in… |
date change Completion pushed: 2032-12-31 -> 2033-01-31 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-05 | NCT07629583 To Evaluate the Effects of Cevostamab in Participants With Systemic Lupus Erythematosus… | Phase 1 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07555938 | Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in… | Multiple Myeloma | Recruiting |
| Phase 1/2 | |||
| NCT05583617 | A Study Evaluating the Safety and Efficacy of Multiple Treatments in Participants With… | Multiple Myeloma | Recruiting |
| NCT05535244 | A Study Evaluating the Efficacy and Safety of Cevostamab in Prior B Cell Maturation… | Multiple Myeloma | Active, Not Recruiting |
| Phase 1 | |||
| NCT05137054 | A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other… | Multiple Myeloma | Recruiting |
| NCT05927571 | A Study Evaluating the Safety, Pharmacokinetics, and Activity of the Combination of… | Relapsed or Refractory Multiple Myeloma | Recruiting |
| NCT06934044 | A Study Evaluating the Pharmacokinetics, Safety, and Efficacy of Cevostamab in Chinese… | Multiple Myeloma | Recruiting |
| NCT04910568 | A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in… | Multiple Myeloma | Active, Not Recruiting |
| NCT05646836 | A Study to Evaluate the Safety, Pharmacokinetics, and Activity of XmAb24306 in… | Multiple Myeloma | Active, Not Recruiting |
| NCT07629583 | To Evaluate the Effects of Cevostamab in Participants With Systemic Lupus Erythematosus… | Lupus Erythematosus, Systemic | Not Yet Recruiting |